Incremental cost-effectiveness of extracorporeal membranous oxygenation as a bridge to cardiac transplant or left ventricular assist device placement in patients with refractory cardiogenic shockCentral MessagePerspective
Objective: Emerging literature has described using venoarterial extracorporeal membranous oxygenation (ECMO) as a bridge to transplant or left ventricular assist device (LVAD) placement. We sought to identify the incremental cost-effectiveness ratio (ICER) of ECMO used as a bridge to cardiac transpl...
Main Authors: | Joseph Reza, MD, Ashley Mila, MD, Bradford Ledzian, PA-C, Jingwei Sun, PhD, Scott Silvestry, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | JTCVS Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666273622002923 |
Similar Items
-
Concomitant use of extracorporeal membrane oxygenation and percutaneous microaxial assist device support for cardiogenic shockCentral MessagePerspective
by: Shan P. Modi, MD, et al.
Published: (2024-02-01) -
Proposal for a trial of early left ventricular venting during venoarterial extracorporeal membrane oxygenation for cardiogenic shockCentral MessagePerspective
by: Michael Ibrahim, MD, PhD, et al.
Published: (2021-12-01) -
Outcomes of patients with COVID-19 supported by venovenous extracorporeal membrane oxygenation for greater than 90 daysCentral MessagePerspective
by: David R. Stern, MD, et al.
Published: (2023-12-01) -
Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation
by: Lauren Dautzenberg, et al.
Published: (2022-12-01) -
Combined mechanical circulatory support for ventricular fibrillation in left ventricular assist device patient
by: Mahmood Abu Akel, et al.
Published: (2022-10-01)